Cytomx TherapeuticsCTMX
13F holders, Q3 2024 (September 30)69holders −5
9new positions
13sold out
3famous investors
$1.18avg. 13F price*
At the end of Q3 2024, 69 institutions reported holding Cytomx Therapeutics Inc. (CTMX) in their 13F filings, down 5 from Q2 2024. 9 opened new positions and 13 sold out. The largest holders were Tang Capital Management LLC ($9.2M), BVF Inc. ($6.2M) and Vanguard Group Inc. ($6.1M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cytomx Therapeutics Inc.
- CUSIP
- 23284F105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $5.3M |
| Exits | 13 | $4.2M |
All 13F filers, Q2 2024 → Q3 2024: 6,971,522 shares bought and 6,440,401 shares sold, net +531,121 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 69 holders
| Tang Capital Management LLC | 0.66% | Add +0.3% | 7,811,760 | $9.2M |
| BVF Inc. | 0.18% | No change | 5,228,461 | $6.2M |
| Vanguard Group Inc. | 0.00% | Add +5.5% | 5,162,302 | $6.1M |
| Janus Henderson Group PLC | 0.00% | Reduce -23.7% | 4,809,518 | $5.7M |
| Acadian Asset Management LLC | 0.01% | Add +13.7% | 3,100,994 | $3.7M |
| Prosight Management, LP | 0.90% | New | 3,022,109 | $3.6M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | No change | 3,000,000 | $3.5M |
| Millennium Management | 0.00% | Add +38.7% | 2,560,256 | $3.0M |
| Assenagon Asset Management S.A. | 0.00% | Add +32.8% | 1,644,168 | $1.9M |
| Jacobs Levy Equity Management, Inc. | 0.01% | Add +1.1% | 1,524,076 | $1.8M |
| Laurion Capital Management LP | 0.10% | Reduce -18.2% | 1,248,364 | $1.5M |
| Congress Park Capital LLC | 0.53% | Add +5.4% | 1,216,008 | $1.4M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -11.9% | 1,211,800 | $1.4M |
| BlackRock, Inc. | 0.00% | — | 1,168,566 | $1.4M |
| Renaissance Technologies | 0.00% | Reduce -14.2% | 1,015,000 | $1.2M |
| Altium Capital Management LLC | 0.32% | New | 915,000 | $1.1M |
| ADAR1 Capital Management, LLC | 0.18% | Add +58.0% | 903,959 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +4.4% | 803,531 | $948K |
| Sei Investments Co. | 0.00% | Add +27.5% | 487,902 | $576K |
| Two Sigma Investments, LP | 0.00% | Reduce -28.8% | 471,468 | $556K |
| Woodline Partners LP | 0.00% | New | 393,832 | $465K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -3.4% | 356,624 | $421K |
| Citadel Advisors | 0.00% | Reduce -35.9% | 317,119 | $374K |
| FMR LLC | 0.00% | Add +17.3% | 284,307 | $335K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +10.4% | 280,593 | $331K |
| State Street Corp. | 0.00% | No change | 263,643 | $311K |
| Formidable Asset Management, LLC | 0.05% | Reduce -4.7% | 246,001 | $290K |
| Tidal Investments LLC | 0.00% | Reduce -4.7% | 246,001 | $290K |
| Bank of New York Mellon Corp | 0.00% | No change | 241,982 | $286K |
| Northern Trust Corp. | 0.00% | Reduce -0.9% | 129,886 | $153K |
| Creative Planning | 0.00% | No change | 107,000 | $126K |
| Virtu Financial LLC | 0.01% | New | 88,518 | $104K |
| UBS Group AG | 0.00% | Reduce -1.8% | 69,135 | $82K |
| Forefront Analytics, LLC | 0.03% | Reduce -6.7% | 59,760 | $71K |
| Qube Research & Technologies Ltd | 0.00% | Add +0.9% | 55,108 | $65K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 54,243 | $64K |
| Private Advisor Group, LLC | 0.00% | No change | 52,179 | $62K |
| Morgan Stanley | 0.00% | Reduce -73.3% | 50,368 | $59K |
| Russell Investments Group, Ltd. | 0.00% | Add +11.3% | 47,649 | $56K |
| Stifel Financial Corp. | 0.00% | Reduce -2.1% | 46,100 | $54K |
| XTX Topco Ltd | 0.00% | Reduce -27.9% | 43,664 | $52K |
| Cornercap Investment Counsel Inc. | 0.01% | Reduce -48.6% | 41,458 | $49K |
| LPL Financial LLC | 0.00% | Add +5.5% | 38,315 | $45K |
| Invesco Ltd. | 0.00% | Add +62.2% | 37,464 | $44K |
| Prudential Financial Inc. | 0.00% | No change | 36,500 | $43K |
| US Bancorp \de | 0.00% | New | 33,792 | $40K |
| AJOVista, LLC | 0.17% | New | 33,121 | $39K |
| Jane Street Group, LLC | 0.00% | Reduce -65.8% | 27,231 | $32K |
| HRT Financial LP | 0.00% | New | 26,840 | $31K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 24,817 | $29K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -70.2% | 24,460 | $29K |
| Bank of America Corp. | 0.00% | Add +258.0% | 20,561 | $24K |
| WestHill Financial Advisors, Inc. | 0.00% | No change | 17,082 | $20K |
| Nierenberg Investment Management Company, LLC | 0.01% | No change | 12,555 | $15K |
| IPG Investment Advisors LLC | 0.00% | No change | 12,500 | $15K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -89.0% | 12,000 | $14K |
| EP Wealth Advisors, LLC | 0.00% | New | 10,432 | $12K |
| Susquehanna International Group, LLP | 0.00% | Reduce -60.3% | 10,304 | $12K |
| Peregrine Asset Advisers, Inc. | 0.00% | New | 10,000 | $12K |
| Ikarian Capital, LLC | 0.00% | No change | 8,924 | $11K |
| Lazard Asset Management LLC | 0.00% | Reduce -52.2% | 8,828 | $10K |
| Group One Trading LLC | 0.00% | Reduce -71.0% | 4,911 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 900 | $1K |
| Bollard Group LLC | 0.00% | No change | 712 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 281 | $332 |
| Raleigh Capital Management Inc. | 0.00% | No change | 250 | $295 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -98.6% | 238 | $281 |
| BNP Paribas Financial Markets | 0.00% | Add +148.7% | 194 | $229 |
| Federated Hermes, Inc. | 0.00% | No change | 117 | $138 |
"% of holder's portfolio" is CTMX's weight in each manager's 13F, not the share of Cytomx Therapeutics Inc. the manager owns.